Mammography Systems Market - By Product (Analog Systems, Full Field Digital Mammography Systems (FFDM), Breast Tomosynthesis), By Technology (Screen Film, 2D Mammography, 3D Mammography), By End-use (Hospitals, Clinics) & Global Forecast, 2023 - 2032

Mammography Systems Market Size

Mammography Systems Market size crossed USD 2.5 billion in 2022 and is set to register over 7.5% CAGR through 2023-2032, owing to the growing incidence of breast cancer.
 

Breast cancer has become a global cause of concern due to its high incidence globally. This common cancer may occur in women with no history or risk factors associated with the disease. As per the American Cancer Society, breast cancer accounts for over 30% of new cancer cases in females each year. The alarming increase in disease prevalence will boost the requirement for regular mammography screening and diagnostic procedures to identify early signs. This medical imaging method can detect cancer areas that are too small to locate during physical examinations.
 

To reduce the disease burden, health organizations including PAHO have launched campaigns to alert caregivers, health professionals, and parents about early cancer signs in adolescents and children. These initiatives to improve timely diagnosis and treatment outcomes will create lucrative growth opportunities for mammography machine developers. However, biomedical research and the early stages of medical development have become more capital-intensive, asserting a negative influence on the market outlook..
 

Mammography Systems Market Analysis

Mammography systems market share from the full field digital mammography product segment will exhibit over 7% CAGR through 2032, considering its ability to provide better image resolution and early cancer detection compared to other machines. Digital mammography permits more accurate and rapid needle placement, thereby speeding the biopsy procedure and lowering discomfort. Moreover, its superior contrast resolution and the ability to manipulate images can ensure more accurate breast cancer detection. These positive features, along with the availability of favorable healthcare reimbursement policies, will accelerate product consumption over the forecast period.
 

Based on the end-use, the mammography systems market size from the ambulatory surgical centers segment is projected to reach more than USD 1.5 billion by 2032. The increasing awareness about the role of ASCs in preventive cancer care and early cancer detection is a factor bolstering the use of mammography equipment. These centers are equipped with advanced tech-powered cancer detection devices for precise diagnostic procedures. Furthermore, good regulatory practices and shorter procedural time are also expected to also fuel the demand for mammography systems in ASCs for cancer diagnosis.
 

From a regional perspective, the North America mammography systems market will be valued at over USD 2 billion by 2032, as a result of the increased incidence of breast cancer. The strong presence of market players involved in the R&D of technology-enabled cancer detection systems is another factor driving market expansion. The number of elderly people susceptible to cancer due to hormonal fluctuation has also surged. In addition, the development of sophisticated healthcare infrastructure will add impetus to the North American market growth.
 

Mammography Systems Market Share

The strategic landscape of the global mammography systems market consists of companies such as:

• Siemens Healthineer
• Planmed Oy
• NP JSC Amico
• Koninklijke Philips N.V.
• Konica Minolta, Inc
•  Hologic
• Fujifilm Holdings Corporation
• Delphinus Medical Technologies
• Carestream Health, Inc.
• Canon Medical Systems Corporation (Toshiba Medical Systems Corp.)
• Analogic Corporation
• and GE Healthcare

. Strategic product launches, partnerships, and acquisitions are some of the initiatives being undertaken by these companies to reinforce their presence and increase their customers in the industry.
 

Impact of inflation on the mammography systems market trends

The rise of inflation at its highest levels in recent years has negatively impacted healthcare operations worldwide. Based on the Medical Care Costs Associated with Cancer Survivorship in the U.S., cancer-related medical care costs are substantial and are set to rise due to the increasing population and other factors. Moreover, medical service and prescription drug costs remain the highest for patients with female breast and other cancers. These factors may limit the adoption of mammography systems for breast cancer diagnosis over the forthcoming years.
 

The mammography systems market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product

• Analog systems
• Full field digital mammography systems
• Breast tomosynthesis systems

By Technology

• Screen film
• 2D mammography
• 3D mammography
• Others

By End-use

• Hospitals
• Ambulatory surgical centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • Switzerland
  • Sweden
  • Denmark
  • The Netherlands
  • Belgium
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Iran